Comparison of multidrug-resistant acinetobacter and non-acinetobacter infections in terms of outcome in critically ill patients

Introduction Acinetobacter infections have increased and gained attention because of the organism’s prolonged environmental survival and propensity to develop antimicrobial drug resistance [1],[2]. We performed a retrospective, matched cohort investigation at a tertiary care hospital in a tier II city hospital of India to examine morbidity and mortality outcome of patients with multidrug-resistant (MDR) Acinetobacter (AB) infection compared with patients with MDR non-Acinetobacter (non-AB) infections.